Lakewood-Amedex Biotherapeutics Inc. (LABT) IPO - S-1 Filing, Stock & Insider Activity
Lakewood-Amedex Biotherapeutics Inc. IPO - Status & S-1 Filing
- Ticker: LABT
- Status: Priced - IPO complete
- S-1 filed: 2026-01-09
- Effective: 2026-05-13
- IPO / pricing date: 2026-04-23
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 9,647,726
- SEC CIK: 0002079272 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Lakewood-Amedex Biotherapeutics Inc. (LABT) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-06. 6 Form 8-K material event filings were reported by LABT in the last 90 days. InsiderAlpha tracks every LABT SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Lakewood-Amedex Biotherapeutics Inc. (LABT)
Lakewood-Amedex Biotherapeutics Inc. trades under the ticker LABT. InsiderAlpha tracks 1 primary SEC Form 4 filing from 1 reporting insider for LABT since 2026, sourced directly from SEC EDGAR.
| SEC CIK | 0002079272 |
|---|
90-Day SEC Filing Activity
| Form 4 filings (90d) | 1 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Latest Form 4 filing | 2026-05-06 |
Most-Active LABT Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Joseph Edward Tucker | 1 | - |
Recent LABT Form 8-K Material Events
- - Item 7.01, 9.01 [SEC]
- - Other · neutral [SEC]
Trading halt (T3) for LABT. LABT - - Other · neutral [SEC]
Trading halt (T3) for LABT. LABT - - Other · neutral [SEC]
Trading halt (T3) for LABT. LABT - - Other · neutral [SEC]
Trading halt (T1) for LABT. LABT
Recent Insider Filings
- - Joseph Edward Tucker (Insider)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in LABT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
LABT Insider Trading - FAQ
- What is the latest insider trade for LABT?
- Lakewood-Amedex Biotherapeutics Inc. (LABT) had 1 insider filings in the last 90 days, with the most recent on 2026-05-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying LABT stock?
- 0 insider purchases of LABT were filed in the last 90 days.
- How many insiders are selling LABT stock?
- 0 insider sales of LABT were filed in the last 90 days.
- Where can I see LABT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks LABT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $LASE Laser Photonics Corp
- $LBRJ Libera Gaming Operations, Inc
- $LBZZ Lendbuzz Inc.
- $LCDC LORENZO DEVELOPMENTS INC.
- $LCLN Lincoln International, Inc.
- $LDDFF LIBERTY DEFENSE HOLDINGS, LTD.
- $LEE LEE ENTERPRISES, Inc
- $LEEEF Leef Brands Inc.
- $LEGO Legato Merger Corp. IV
- $LFAC Leapfrog Acquisition Corp
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live LABT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.